Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane mesylate in Congenital and Acquired Nystagmus
NCT00661440Phase 2Completed
- Sponsor
- Merz
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neramexane in congenital idiopathic nystagmus (CIN) and Acquired nystagmus (2 arms), sponsored by Merz. Primary endpoint: Visual acuity. Started May 2008; status: completed.
02
Drugs
neramexane
03
Conditions
congenital idiopathic nystagmus (CIN)Acquired nystagmus
Beyond the preview
Go deeper on NCT00661440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661440.